Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

被引：0
|
作者：
Philip J. Mease
Alexis Ogdie
John Tesser
Natalie J. Shiff
Iris Lin
Soumya D. Chakravarty
Michael Kelleman
Rhiannon Dodge
Robert R. McLean
Aaron Broadwell
Arthur Kavanaugh
Joseph F. Merola
机构：
[1] Swedish Medical Center/Providence St. Joseph Health and University of Washington,Brigham and Women’s Hospital
[2] University of Pennsylvania School of Medicine,undefined
[3] Arizona Arthritis and Rheumatology Associates,undefined
[4] P.C.,undefined
[5] Janssen Scientific Affairs,undefined
[6] LLC,undefined
[7] University of Saskatchewan,undefined
[8] Drexel University College of Medicine,undefined
[9] CorEvitas,undefined
[10] LLC,undefined
[11] Rheumatology and Osteoporosis Specialists,undefined
[12] University of California San Diego,undefined
[13] Harvard Medical School,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Psoriatic arthritis; Biologics; Guselkumab; Real-world evidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1479 / 1501
页数：22
相关论文
共 50 条
  • [1] Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Ogdie, Alexis
    Tesser, John
    Shiff, Natalie J.
    Lin, Iris
    Chakravarty, Soumya D.
    Kelleman, Michael
    Dodge, Rhiannon
    McLean, Robert R.
    Broadwell, Aaron
    Kavanaugh, Arthur
    Merola, Joseph F.
    RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1479 - 1501
  • [2] Real-World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    O'Brien, Jacqueline
    Middaugh, Nicole
    Kricorian, Gregory
    Stryker, Scott
    Collier, David H.
    Ogdie, Alexis
    ACR OPEN RHEUMATOLOGY, 2023, 5 (08) : 388 - 398
  • [3] REAL-WORLD EVIDENCE ON ASSESSING PSORIATIC ARTHRITIS BY DISEASE DOMAIN: AN EVALUATION OF THE COREVITAS PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS REGISTRY
    Mease, P. J.
    Blachley, T.
    O'brien, J.
    Middaugh, N.
    Kricorian, G.
    Stryker, S.
    Collier, D.
    Ogdie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 406 - 407
  • [4] Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Ogdie, Alexis
    Tesser, John
    Shiff, Natalie J.
    Zhao, Ruizhi Sophia
    Chakravarty, Soumya D.
    Kelleman, Michael
    Dodge, Rhiannon
    McLean, Robert R.
    Broadwell, Aaron
    Kavanaugh, Arthur
    Merola, Joseph F.
    ACR OPEN RHEUMATOLOGY, 2024, 6 (05) : 304 - 311
  • [5] Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Philip J. Mease
    Alexis Ogdie
    Soumya D. Chakravarty
    Natalie J. Shiff
    Iris Lin
    Robert R. McLean
    Wendi Malley
    Rebecca L. Spitzer
    Arthur Kavanaugh
    Joseph F. Merola
    Drugs - Real World Outcomes, 2022, 9 : 617 - 628
  • [6] Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Ogdie, Alexis
    Chakravarty, Soumya D.
    Shiff, Natalie J.
    Lin, Iris
    McLean, Robert R.
    Malley, Wendi
    Spitzer, Rebecca L.
    Kavanaugh, Arthur
    Merola, Joseph F.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (04) : 617 - 628
  • [7] Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/ Spondyloarthritis Registry
    Mease, Philip J.
    Blachley, Taylor
    Dube, Blessing
    McLean, Robert R.
    Kim, Nina
    Hur, Peter
    Ogdie, Alexis
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 700 - 706
  • [8] Real-World Efficacy of TNF Inhibitors for Treatment of Psoriatic Arthritis by Disease Domains: 6-Month Findings from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip
    Blachley, Taylor
    O'Brien, Jacqueline
    Middaugh, Nicole
    Kricorian, Greg
    Stryker, Scott
    Collier, David
    Ogdie-Beatty, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3792 - 3795
  • [9] Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Philip J. Mease
    Pamela Young
    Lara Fallon
    Rajiv Mundayat
    Oluwaseyi Dina
    Taylor Blachley
    Nicole Middaugh
    Alexis Ogdie
    Rheumatology and Therapy, 2024, 11 : 313 - 329
  • [10] Improvements in Patient-Reported Outcomes Through 6 Months of Guselkumab Treatment in Patients with Active Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
    Mease, Philip J.
    Ogdie, Alexis R.
    Tesser, John
    Shiff, Natalie
    Lin, Iris
    Chakravarty, Soumya
    Kelleman, Mike
    Dodge, Rhiannon
    McLean, Robert
    Broadwell, Aaron
    Kavanaugh, Arthur
    Merola, Joseph F.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2767 - 2770
12345